IL87543A0 - Interleukin 1 inhibitors,methods for the purification thereof and pharmaceutical compositions containing the same - Google Patents

Interleukin 1 inhibitors,methods for the purification thereof and pharmaceutical compositions containing the same

Info

Publication number
IL87543A0
IL87543A0 IL87543A IL8754388A IL87543A0 IL 87543 A0 IL87543 A0 IL 87543A0 IL 87543 A IL87543 A IL 87543A IL 8754388 A IL8754388 A IL 8754388A IL 87543 A0 IL87543 A0 IL 87543A0
Authority
IL
Israel
Prior art keywords
inhibitors
methods
interleukin
inhs
purification
Prior art date
Application number
IL87543A
Other languages
English (en)
Original Assignee
Biogen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22218720&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL87543(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Biogen Inc filed Critical Biogen Inc
Publication of IL87543A0 publication Critical patent/IL87543A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Pyridine Compounds (AREA)
IL87543A 1987-08-26 1988-08-23 Interleukin 1 inhibitors,methods for the purification thereof and pharmaceutical compositions containing the same IL87543A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8963287A 1987-08-26 1987-08-26

Publications (1)

Publication Number Publication Date
IL87543A0 true IL87543A0 (en) 1989-01-31

Family

ID=22218720

Family Applications (1)

Application Number Title Priority Date Filing Date
IL87543A IL87543A0 (en) 1987-08-26 1988-08-23 Interleukin 1 inhibitors,methods for the purification thereof and pharmaceutical compositions containing the same

Country Status (20)

Country Link
EP (1) EP0341273B1 (de)
JP (2) JP3014099B2 (de)
KR (2) KR0138919B1 (de)
AT (1) ATE147408T1 (de)
AU (1) AU633471B2 (de)
BE (1) BE1002375A3 (de)
CA (1) CA1341026C (de)
DE (1) DE3855747T2 (de)
DK (1) DK175837B1 (de)
ES (3) ES2015348A6 (de)
FR (1) FR2621821A1 (de)
GB (1) GB2220662A (de)
HK (1) HK1007748A1 (de)
IL (1) IL87543A0 (de)
IT (1) IT1226855B (de)
NL (1) NL8820676A (de)
NZ (1) NZ225940A (de)
SE (1) SE8901342L (de)
WO (1) WO1989001946A1 (de)
ZA (1) ZA886251B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6159460A (en) * 1988-05-27 2000-12-12 Amgen Inc. Method for treating interleukin-1 mediated diseases
US6858409B1 (en) 1988-05-27 2005-02-22 Amgen Inc. Nucleic acids encoding interleukin-1 inhibitors and processes for preparing interleukin-1 inhibitors
US5075222A (en) * 1988-05-27 1991-12-24 Synergen, Inc. Interleukin-1 inhibitors
HU9803037D0 (en) * 1988-05-27 1999-11-29 Synergen Inc Interleukin-1 inhibitors
KR0148009B1 (ko) * 1988-05-27 1998-08-01 그래고리 비. 아보트 인터루킨-1 억제제
HUT64582A (en) * 1989-11-29 1994-01-28 Synergen Inc Method for producing recombinant human interleukin-1 inhibitor
US5714140A (en) * 1989-12-13 1998-02-03 Otsuka Pharmaceutical Co., Ltd. Method for inhibiting the production of bioactive IL-1 by administering M-CSF
US6552170B1 (en) 1990-04-06 2003-04-22 Amgen Inc. PEGylation reagents and compounds formed therewith
AU7683391A (en) * 1990-04-27 1991-11-27 Upjohn Company, The Modified interleukin-1 inhibitors
EP0534978B1 (de) * 1990-05-01 1999-03-24 Chiron Corporation Interleukin-i antagonist und seine verwendung
EP0850061A1 (de) * 1995-09-13 1998-07-01 Takeda Chemical Industries, Ltd. Immunosuppressivum
US6294170B1 (en) 1997-08-08 2001-09-25 Amgen Inc. Composition and method for treating inflammatory diseases

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4992367A (en) * 1986-05-12 1991-02-12 Hoffmann-La Roche Inc. Enhanced expression of human interleukin-2 in mammalian cells

Also Published As

Publication number Publication date
DK203189A (da) 1989-04-26
DE3855747D1 (de) 1997-02-20
CA1341026C (en) 2000-06-13
ES2017274A6 (es) 1991-01-16
ES2017275A6 (es) 1991-01-16
DK175837B1 (da) 2005-03-21
NL8820676A (nl) 1989-07-03
EP0341273A1 (de) 1989-11-15
ES2015348A6 (es) 1990-08-16
KR0138654B1 (ko) 1998-04-30
JPH10327862A (ja) 1998-12-15
KR0138919B1 (ko) 1998-04-30
SE8901342D0 (sv) 1989-04-13
AU633471B2 (en) 1993-02-04
EP0341273A4 (en) 1990-09-19
NZ225940A (en) 1992-06-25
AU2427288A (en) 1989-03-31
DK203189D0 (da) 1989-04-26
JP3217752B2 (ja) 2001-10-15
WO1989001946A1 (en) 1989-03-09
BE1002375A3 (fr) 1991-01-22
GB2220662A (en) 1990-01-17
ZA886251B (en) 1990-04-25
JPH02500643A (ja) 1990-03-08
ATE147408T1 (de) 1997-01-15
JP3014099B2 (ja) 2000-02-28
EP0341273B1 (de) 1997-01-08
FR2621821A1 (fr) 1989-04-21
GB8912533D0 (en) 1989-08-02
SE8901342L (sv) 1989-04-13
DE3855747T2 (de) 1997-06-12
KR890701629A (ko) 1989-12-21
HK1007748A1 (en) 1999-04-23
IT1226855B (it) 1991-02-19
IT8821743A0 (it) 1988-08-25

Similar Documents

Publication Publication Date Title
ATE113295T1 (de) Tumornekrosefaktor, verfahren zu seiner herstellung, denselben enthaltende zusammensetzungen, dafür kodierende dns und diese dns verwendendes testverfahren.
DK0398327T4 (da) Tumornekrosefaktor-bindende protein, dets oprensning og antistoffer dertil
GB9323165D0 (en) Compounds
GB8912533D0 (en) Biological materials,processes for producing biological materials and for using such materials in therapy
DK1240337T3 (da) Fremgangsmåder og præparater til forlængelse af elimeneringshalveringstider af bioaktive forbindelser
DE69433666D1 (de) ENTZÜNDUNGSPROTEINE AUS MAKROPHAGEN MIP-3, MIP-4 UND MIP-1Gamma
EP1449849A3 (de) Protease-resistentes Thrombomodulinanalog
HUT43106A (en) Dns sequences koding proteins of flesh-i type inhibitor activity and process for producing these proteins
ATE385517T1 (de) Interferon ähnliche moleküle, und deren verwendungen
ES2170747T3 (es) Analogos superiores de trombomodulina para uso farmaceutico.
DE69416103D1 (de) Verdrängungschromatographisches verfahren und gereinigtes hämoglobin
EP1757311A3 (de) Verfahren und Zusammensetzungen zur Verlängerung der Entsorgungshalbwertszeit von biowirksamen Verbindungen
ATE159032T1 (de) Anti-hiv protein, tap-29, aus trichosanthes, seine kodierende dna und therapeutischen anwendungen
IT8720034A0 (it) Composizioni farmaceutiche per il trattamento di sindromi psico-organiche cerebrali.
Dayer et al. Interkeukin-1 inhibitor
MY134493A (en) Thrombopoietin peptides, fragments, nucleic acids encoding the same, and method
BG101847A (bg) Варианти на човешка дезоксирибонуклеаза i

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired
EXP Patent expired